Literature DB >> 26191558

Development of Primary Immunodeficiencies in Africa.

A A Bousfiha, L Jeddane, N Erwa, T N Dieye, F Mellouli, S M Reda, M Esser, R Boukari.   

Abstract

Entities:  

Mesh：

Year:  2015        PMID： 26191558     DOI： 10.1007/s10875-015-0162-4

Source DB:  PubMed          Journal:  J Clin Immunol        ISSN： 0271-9142            Impact factor:   8.317


× No keyword cloud information.
  5 in total

1.  First report on the Moroccan registry of primary immunodeficiencies: 15 years of experience (1998-2012).

Authors:  A A Bousfiha; L Jeddane; N El Hafidi; N Benajiba; N Rada; J El Bakkouri; A Kili; S Benmiloud; I Benhsaien; I Faiz; O Maataoui; Z Aadam; A Aglaguel; L Ait Baba; Z Jouhadi; R Abilkassem; M Bouskraoui; M Hida; J Najib; H Salih Alj; F Ailal
Journal:  J Clin Immunol       Date:  2014-03-12       Impact factor: 8.317

2.  Primary immunodeficiencies in highly consanguineous North African populations.

Authors:  Mohamed-Ridha Barbouche; Nermeen Galal; Imen Ben-Mustapha; Leïla Jeddane; Fethi Mellouli; Fatima Ailal; Mohamed Bejaoui; Jeanette Boutros; Aisha Marsafy; Ahmed Aziz Bousfiha
Journal:  Ann N Y Acad Sci       Date:  2011-11       Impact factor: 5.691

3.  From genotype to phenotype. Further studies measuring the impact of a Physician Education and Public Awareness Campaign on early diagnosis and management of primary immunodeficiencies.

Authors:  Fred Modell; Diana Puente; Vicki Modell
Journal:  Immunol Res       Date:  2009       Impact factor: 2.829

4.  Primary immunodeficiency diseases worldwide: more common than generally thought.

Authors:  Ahmed Aziz Bousfiha; Leïla Jeddane; Fatima Ailal; Ibtihal Benhsaien; Nizar Mahlaoui; Jean-Laurent Casanova; Laurent Abel
Journal:  J Clin Immunol       Date:  2012-07-31       Impact factor: 8.317

5.  Global overview of primary immunodeficiencies: a report from Jeffrey Modell Centers worldwide focused on diagnosis, treatment, and discovery.

Authors:  Vicki Modell; Megan Knaus; Fred Modell; Chaim Roifman; Jordan Orange; Luigi D Notarangelo
Journal:  Immunol Res       Date:  2014-10       Impact factor: 2.829
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.